Serina Therapeutics Inc (SER) Stock Price, Quote & News

Company Profile

Serina Therapeutics, Inc., a biotechnology company, develops drugs to treat neurological diseases and pain. Its lead product candidate is SER 252 (POZ-apomorphine), a POZ conjugate for the treatment of advanced Parkinson's disease that is in preclinical stage development; and POZ-lipids, a non-immunogenic alternative to the PEG-lipids in the lipid nanoparticles. The company also develops SER 214 a POZ conjugate of rotigotine for the treatment of early Parkinson's and Restless Leg Syndrome, which...

Industry: Biotechnology

Sector: Healthcare

Phone: 256 327 9630

Website: serinatherapeutics.com

Address:

601 Genome Way, Suite 2001, Huntsville, United States

TALENT_ON_LOAN_FROM_GOD Mar. 19 at 12:15 AM

$LBGJ 🤓☝️1.3B VOLUME LET THAT SINK IN $ASNS $SER $SUNE $SVRN

0 · Reply

jackrabbit1 Mar. 19 at 12:10 AM

$SER $MDAI looking for 2 plus tomorrow

0 · Reply

newyork1979 Mar. 18 at 11:59 PM

TAOP could easily 3X from here - 900k FLoat with no dilution - Robotics / AI merger coming with a company that has HUGE customers like mcdonalds/KFC/Starbucks - TAOP is only valued around $12M , very undervalued. - Shorts are trapped and will be forced to buyback all their shares which will cause a Mother of all short squeezes. $SBDS $SER $SVRN $MDAI $LBGJ PM watchers

0 · Reply

j2012 Mar. 18 at 11:57 PM

$SER holding for tomorrow's PM action should stay #1 on list when PM opens, until tomorrow followers! GL & GN

0 · Reply

BullishStockCatcher Mar. 18 at 11:53 PM

Into the Close Bullish list 💹 $LBGJ $SVRN $ASNS $SUNE $SER Stay green everyone ✅

0 · Reply

InfernoWyrm Mar. 18 at 11:45 PM

$BLSH $DUOL $ALDX $SER rer

0 · Reply

AlertsAndNews Mar. 18 at 11:34 PM

Gappers here in after hours trading $SER $SVRN $MDAI $ASNS $SUNE I'll try and update later this evening.

0 · Reply

globaldaytraderzzz Mar. 18 at 11:20 PM

$SER

0 · Reply

StockFlips Mar. 18 at 11:19 PM

Mains 🔥🪽 $SER $ASNS $RAIN $SBDS $IBG

0 · Reply

StuartYanni Mar. 18 at 11:19 PM

$SBDS 600k FLOAT ... 0 DILUTION ... EARNINGS TOMORROW.. SQUEEZE LIKE $SER $MDAI $SUNE

1 · Reply

Serina Therapeutics Secures up to $30 Million in Private Placement to Advance Registrational Trial of SER-252 for Advanced Parkinson's Disease

Feb 24, 2026, 4:05 PM EST - 22 days ago

Serina Therapeutics Announces Dosing of First Patient in Phase 1b Registrational Trial of SER-252 for Advanced Parkinson's Disease

Feb 19, 2026, 6:00 AM EST - 27 days ago

Serina Therapeutics Announces First Patient Enrolled in Phase 1b Registrational Trial of SER-252 for Advanced Parkinson's Disease

Feb 3, 2026, 6:00 AM EST - 6 weeks ago

Registration Is Now Open For Tribe Public's CEO Presentation and Q&A Webinar Event

Jan 28, 2026, 4:12 PM EST - 7 weeks ago

Serina Therapeutics Announces FDA Clearance of IND Application for SER-252 for the Treatment of Advanced Parkinson's disease

Jan 15, 2026, 4:30 PM EST - 2 months ago

Serina Therapeutics Receives NYSE Deficiency Notification Regarding Shareholders' Equity

Dec 11, 2025, 4:15 PM EST - 3 months ago

Serina Therapeutics Strengthens Leadership Team with Appointment of Dr. Joshua Thomas as VP, Head of Chemistry

Dec 10, 2025, 4:30 PM EST - 3 months ago

Serina Therapeutics Submits Complete Response to FDA Clinical Hold Letter for SER-252 Program

Nov 13, 2025, 6:10 AM EST - 4 months ago

Serina Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Highlights

Nov 3, 2025, 6:05 AM EST - 4 months ago

Serina Therapeutics Provides Regulatory Update on SER-252 Program

Oct 8, 2025, 11:00 AM EDT - 5 months ago

Serina Therapeutics Launches Enhanced Corporate Communications Platform to Strengthen Engagement with Patients, Clinicians, and Investors

Oct 6, 2025, 4:15 PM EDT - 5 months ago

Serina Therapeutics Draws First $5 Million Funding Tranche to Support Registrational Trial of SER-252 in Parkinson's Disease

Sep 9, 2025, 3:20 PM EDT - 6 months ago

Serina Therapeutics Secures Up to $20 Million to Advance Registrational Trial of SER-252 in Parkinson's Disease

Sep 8, 2025, 6:00 AM EDT - 6 months ago

Serina Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Aug 25, 2025, 4:15 PM EDT - 7 months ago

Serina Therapeutics Announces FDA Feedback Supports Registrational Trial Design of SER-252 in Advanced Parkinson's Disease under 505(b)(2) NDA Pathway

Aug 11, 2025, 4:30 PM EDT - 7 months ago

Serina Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Highlights

Jul 29, 2025, 6:44 AM EDT - 8 months ago

Serina Therapeutics Advances POZ-VMAT2i into Development for Tardive Dyskinesia (TD)

Jul 28, 2025, 6:00 AM EDT - 8 months ago

Serina Therapeutics to Present at the BTIG Virtual Biotechnology Conference

Jul 10, 2025, 4:10 PM EDT - 8 months ago

Serina Therapeutics Makes Grant to New Employee Under Inducement Plan

Jul 1, 2025, 4:15 PM EDT - 9 months ago

Serina Therapeutics Announces Date for 2025 Annual Stockholders Meeting

Jun 23, 2025, 7:24 PM EDT - 9 months ago

Serina Therapeutics to Present at FORCE Family Office Investor Webinar on June 26, 2025

Jun 17, 2025, 8:30 PM EDT - 9 months ago

UPDATED: Serina Therapeutics Congratulates Juvenescence Ltd. on $76M First Tranche Close of Series B Funding and Strategic Partnership with M42

Jun 17, 2025, 6:00 AM EDT - 9 months ago

Serina Therapeutics Congratulates Juvenescence Ltd. on $150M Series B Funding and Strategic Partnership with M42

Jun 9, 2025, 4:05 PM EDT - 10 months ago

Registration Is Now Open For Tribe Public's CEO Presentation and Q&A Webinar Event "Is the Beaten Down Biotech Sector the Smartest Bet in Today's Volatile Market?"

May 22, 2025, 4:50 PM EDT - 10 months ago

Serina Therapeutics Appoints Stephen Brannan, M.D. to Board of Directors

May 14, 2025, 3:15 PM EDT - 11 months ago

Serina Therapeutics Makes Grants to New Employees Under Inducement Plan

May 8, 2025, 4:23 PM EDT - 11 months ago

Serina Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Highlights

Apr 29, 2025, 6:00 AM EDT - 11 months ago

Serina Therapeutics to Present at JonesResearch Virtual CNS Day

Apr 15, 2025, 6:30 AM EDT - 1 year ago

Serina Therapeutics to Present at the 4th LNP Formulation & Process Development Summit

Apr 8, 2025, 4:30 PM EDT - 1 year ago

Serina Therapeutics Secures $5 Million in Funding to Support Advancement of SER-252 into Clinical Development in Advanced Parkinson's Disease

Apr 7, 2025, 6:30 AM EDT - 1 year ago

Serina Therapeutics to Present at the Jones Healthcare and Technology Innovation Conference

Mar 24, 2025, 4:30 PM EDT - 1 year ago

Serina Therapeutics Reports Full Year 2024 Financial Results and Recent Business Highlights

Mar 24, 2025, 6:30 AM EDT - 1 year ago

Serina Therapeutics to Present at the American Chemistry Society (ACS) Spring 2025 Meeting

Feb 12, 2025, 4:15 PM EST - 1 year ago

Serina Therapeutics Appoints Dr. Jay Venkatesan to its Board of Directors

Feb 3, 2025, 4:30 PM EST - 1 year ago

Serina Therapeutics Receives Second $5 Million Tranche to Strengthen Cash Position Ahead of Phase 1 Clinical Trial in Advanced Parkinson's Disease Patients

Jan 15, 2025, 4:05 PM EST - 1 year ago

Serina Therapeutics Announces Sale of UniverXome Subsidiary

Jan 14, 2025, 5:25 PM EST - 1 year ago

Serina Therapeutics Welcomes Karen J. Wilson to its Board of Directors

Dec 16, 2024, 6:00 AM EST - 1 year ago

Serina Therapeutics to Present at Tribe Public's Webinar Event "Enabling Continuous Drug Delivery for Parkinson's Disease & Beyond" on Wednesday, December 18, 2024

Dec 11, 2024, 6:05 AM EST - 1 year ago

Serina Therapeutics to Present at the 3rd Annual LNP Immunogenicity & Toxicity Summit

Dec 2, 2024, 5:22 PM EST - 1 year ago

Serina Therapeutics Secures $10 Million Financing to Continue Advancing Lead IND Candidate into Phase 1 Clinical Trial in Advanced Parkinson's Disease Patients

Nov 12, 2024, 5:00 PM EST - 1 year ago

Serina Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Highlights

Sep 4, 2024, 6:42 PM EDT - 1 year ago

Serina Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Aug 9, 2024, 4:15 PM EDT - 1 year ago

Serina Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Highlights

Jul 29, 2024, 8:30 AM EDT - 1 year ago

Serina Therapeutics to Present Novel Data on POZ-Lipid Technology Potentially Enhancing Safety and Efficacy of mRNA LNP Formulations at the 4th mRNA-Based Therapeutics Summit

Jul 18, 2024, 5:00 PM EDT - 1 year ago

Serina Therapeutics Appoints Srini Tenjarla, Ph.D. as Senior Vice President of CMC and Formulation

May 14, 2024, 4:05 PM EDT - 2 years ago

Serina Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Highlights

Apr 17, 2024, 4:05 PM EDT - 2 years ago

Serina Therapeutics Appoints Dr. Simba Gill as Executive Chairman

Mar 26, 2024, 5:04 PM EDT - 2 years ago

Serina Therapeutics Announces Completion of Merger with AgeX Therapeutics

Mar 22, 2024, 5:27 PM EDT - 2 years ago

AgeX Therapeutics Reports Fourth Quarter and Annual 2023 Financial Results

Feb 27, 2024, 3:19 PM EST - 2 years ago

AGEX THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of AgeX Therapeutics, Inc. - AGE

TALENT_ON_LOAN_FROM_GOD Mar. 19 at 12:15 AM

$LBGJ 🤓☝️1.3B VOLUME LET THAT SINK IN $ASNS $SER $SUNE $SVRN

0 · Reply

jackrabbit1 Mar. 19 at 12:10 AM

$SER $MDAI looking for 2 plus tomorrow

0 · Reply

newyork1979 Mar. 18 at 11:59 PM

0 · Reply

j2012 Mar. 18 at 11:57 PM

$SER holding for tomorrow's PM action should stay #1 on list when PM opens, until tomorrow followers! GL & GN

0 · Reply

BullishStockCatcher Mar. 18 at 11:53 PM

Into the Close Bullish list 💹 $LBGJ $SVRN $ASNS $SUNE $SER Stay green everyone ✅

0 · Reply

InfernoWyrm Mar. 18 at 11:45 PM

$BLSH $DUOL $ALDX $SER rer

0 · Reply

AlertsAndNews Mar. 18 at 11:34 PM

Gappers here in after hours trading $SER $SVRN $MDAI $ASNS $SUNE I'll try and update later this evening.

0 · Reply

globaldaytraderzzz Mar. 18 at 11:20 PM

$SER

0 · Reply

StockFlips Mar. 18 at 11:19 PM

Mains 🔥🪽 $SER $ASNS $RAIN $SBDS $IBG

0 · Reply

StuartYanni Mar. 18 at 11:19 PM

$SBDS 600k FLOAT ... 0 DILUTION ... EARNINGS TOMORROW.. SQUEEZE LIKE $SER $MDAI $SUNE

1 · Reply

bigtradesgg Mar. 18 at 10:59 PM

$SVRN can be pm top ripper ww $SER

0 · Reply

BryanGreenwater Mar. 18 at 10:47 PM

$SER Holding, reward outweighs the risk

0 · Reply

IBOTTheDipAndTheDipWon Mar. 18 at 10:43 PM

$SER That wedge is about to give way ...

0 · Reply

KevMomentum Mar. 18 at 10:39 PM

$SER - "Serina Therapeutics secures up to $30M in private placement" 4.4x relative volume here in after-hours, and if this can hold up in pre-market tomorrow, I'll look for entry opportunities on the simple break + base over a.h. supply. No break = no trade, range to $2.5, 3.2, 3.6+

0 · Reply

onethetrailofmoney Mar. 18 at 10:35 PM

$SER

0 · Reply

Revempire Mar. 18 at 10:26 PM

JAGU ✅ Starting to get found, massive potential on this! Make sure to put JAGU on your watchlist. Beaten down IPO now starting to reverse/news yesterday. JAGU uranium/rare earth play, hot sector right now, don't miss this gem! JAGU: ✅23M in cash ✅4$ IPO a month ago ✅No dilution filed ✅Positioned in a growing sector ✅Insiders shares are locked 6 months ✅Laguna salada project covers 230 000 hectares $ORBS $SER $AIM $FMFC great day.

0 · Reply

jheerdink Mar. 18 at 10:25 PM

$SER Serina Therapeutics Secures https://vistapglobal.com/serina-therapeutics-secures-30-million-reasons-wall-street-is-warming-to-parkinsons-innovation-ser-ibb-xbi/

0 · Reply

BullishStockCatcher Mar. 18 at 10:19 PM

After hours Bullish list ✅ $LBGJ $SVRN $ASNS $BURU $SER

0 · Reply

IBOTTheDipAndTheDipWon Mar. 18 at 10:11 PM

$SER What is the point of your silly posts? Meanwhile, every little pump gets weaker and weaker.

0 · Reply

Aburose Mar. 18 at 10:09 PM

$SER What is the point of announcement ?

0 · Reply

Aburose Mar. 18 at 9:59 PM

$SER If this announcement had been in a different sector than this sector , it would have been over 300% by now.

0 · Reply

RazorbackAJ Mar. 18 at 9:51 PM

$SER Great place to add to short here with target still $1.25 and stop at $2.10. Follow for such precise calls with exact stop loss levels.

0 · Reply

Market Cap	16.72M
Revenue (ttm)	60,000.00
Net Income (ttm)	-11.14M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-18,566.67%
Debt to Equity Ratio	0.00

Volume	7,069,900
Avg Vol	1,650,684
Day's Range	N/A - N/A
Shares Out	10.79M
Stochastic %K	9%
Beta	1.25
Analysts	Strong Sell
Price Target	$13.00